Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence

Recurrent major depressive disorder (rMDD) is a relapsing-remitting disease with high morbidity and a 5-year risk of recurrence of up to 80%. This was a prospective pilot study to examine the potential diagnostic and prognostic value of targeted plasma metabolomics in the care of patients with rMDD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Psychiatry
Autors principals: Mocking, Roel J. T., Naviaux, Jane C., Li, Kefeng, Wang, Lin, Monk, Jonathan M., Bright, A. Taylor, Figueroa, Caroline A., Schene, Aart H., Ruhé, Henricus G., Assies, Johanna, Naviaux, Robert K.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7801396/
https://ncbi.nlm.nih.gov/pubmed/33431800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-020-01182-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars